Original article
Antroduodenal motility in children with chronic intestinal pseudo-obstruction1

https://doi.org/10.1016/S0022-3476(88)80211-7Get rights and content

Chronic intestinal pseudo-obstruction describes a heterogenous group of disorders characterized by signs and symptoms of intestinal obstruction in the absence of a mechanical lesion. We studied antroduodenal motility in 13 children with pseudo-obstruction. The diagnosis was based on radiographic evidence in all, surgery in 11, and specific pathologic features in four. Antroduodenal motility was abnormal in all 13. Qualitative abnormalities in the patterns of antroduodenal contractions permitted separation into groups: (1) postprandial hypomotility (n=3), (2) absent migrating motor complexes, with phase 3-like activity at the start of meals (neuropathic variety) (n=5), (3) very low amplitude or absent contractions (myopathic variety) (n=2); the remaining patients (n=3) had other distinctive abnormalities. Cisapride, a new gastrointestinal prokinetic drug, stimulated proximal duodenal contractions in the 30 minutes after a meal in nine of 10 patients tested. These studies indicate that antroduodenal manometry is useful for characterizing intestinal pseudoobstruction, and cisapride stimulates postprandial duodenal contractions in patients with pseudo-obstruction.

Cited by (76)

  • Chronic Intestinal Pseudo-Obstruction

    2020, Pediatric Gastrointestinal and Liver Disease, Sixth Edition
  • Chronic intestinal pseudo-obstruction

    2007, Best Practice and Research in Clinical Gastroenterology
    Citation Excerpt :

    Small bowel manometry may also help to differentiate mechanical from functional obstruction, the former being characterised by postprandial, prolonged, high pressure, non-propagated contractions, although mixed patterns can be found in patients who underwent abdominal surgeries.33 Table 2 summarises the main manometric abnormalities described in patients affected by CIPO.2,3,32,35–43 Only a few studies have investigated some aspects of the clinical outcome of CIPO.2,32,37,39–42,44,45

  • Gastric Motility Disorders

    2006, Pediatric Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management
  • Gastric Motility Disorders

    2006, Pediatric Gastrointestinal and Liver Disease
View all citing articles on Scopus
1

Supported in part by NIH-GCRC Grant RR00425 and by Janssen Pharmaceutica.

View full text